News
Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...
A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...
If you’re looking to restock your daily sunscreen, then you’re in luck, because dermatologist-recommended Tizo2 SPF 40 is a ...
Finding an SPF you want to slather all over your face every morning isn’t easy—but the best tinted sunscreen can truly change ...
Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results